Anti-Human CCL21 Recombinant Antibody scFv Fragment (MOR06935_g3-23_g3j (also known as QBP359)) (CAT#: TAB-1495CL-S(P))
This antibody can bind to human CCL21 (hCCL21) and it can be used in the treatment and/or prevention of human diseases and disorders, particularly those of a fibrotic nature.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/51210/140347_A_8_8_selected.jpg

* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/51210/140347_B_9_5_val_selected.jpg

(Glandular cells Staining: Low Intensity: Weak Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/51210/140347_A_8_3.jpg

(Germinal center cells Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous Non-germinal center cells Staining: Not detected Intensity: Weak Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/51210/140347_A_8_8.jpg

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000137077-CCL21
Specifications
- Host Species
- Human
- Type
- Fully human antibody
- Specificity
- Human
- Species Reactivity
- Cyno CCL21
- Clone
- MOR06935_g3-23_g3j (also known as QBP359)
- Related Disease
- Pulmonary fibrosis (e.g. IPF), chronic obstructive pulmonary disease (COPD), hepatic fibrosis, rheumatoid arthritis, congestive heart failure, chronic renal disease and so on.
Target
- Alternative Names
- CCL21; chemokine (C-C motif) ligand 21; ECL; SLC; CKb9; TCA4; 6Ckine; SCYA21; C-C motif chemokine 21; beta chemokine exodus-2; secondary lymphoid tissue chemokine; Efficient Chemoattractant for Lymphocytes; small inducible cytokine subfamily A (Cys-Cys), member 21
- Gene ID
- 6366
- UniProt ID
- O00585
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone MOR06935_g3-23_g3j (also known as QBP359)"
See other products for "CCL21"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1495CL | Anti-Human CCL21 Recombinant Antibody (MOR06935_g3-23_g3j (also known as QBP359)) | FuncS | Fully human antibody |
TAB-1495CL-F(E) | Anti-Human CCL21 Recombinant Antibody Fab Fragment (MOR06935_g3-23_g3j (also known as QBP359)) | FuncS | Fully human antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-1495CL-S(P). Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: WB, ELISA, IP, FC, FuncS, Neut, IF
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: WB, Neut, ELISA, IF, IP, FuncS, FC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: IB, ELISA, FC, FuncS
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.